Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Summit Therapeutics (SMMT) Loans and Notes Receivables (2017)

Historic Loans and Notes Receivables for Summit Therapeutics (SMMT) over the last 1 years, with Q1 2017 value amounting to $35.3 billion.

  • Summit Therapeutics' Loans and Notes Receivables changed N/A to $35.3 billion in Q1 2017 from the same period last year, while for Jan 2017 it was $35.3 billion, marking a year-over-year change of. This contributed to the annual value of $38.0 billion for FY2017, which is N/A changed from last year.
  • As of Q1 2017, Summit Therapeutics' Loans and Notes Receivables stood at $35.3 billion.
  • In the past 5 years, Summit Therapeutics' Loans and Notes Receivables registered a high of $35.3 billion during Q1 2017, and its lowest value of $35.3 billion during Q1 2017.